Crystalline forms of a brutons tyrosine kinase inhibitor
US-2026062417-A1 · Mar 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Goldman Erick patents
Goldman Erick is listed as an inventor on 49 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Goldman Erick |
| Total patents | 49 |
| First publication | Mar 29, 2016 |
| Latest publication | Mar 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Synthesis of a bruton's tyrosine kinase inhibitor
US-2025197404-A1 · Jun 19, 2025 · US
Crystalline forms of a bruton's tyrosine kinase inhibitor
US-2024409545-A1 · Dec 12, 2024 · US
Synthesis of a bruton's tyrosine kinase inhibitor
US-2024158400-A1 · May 16, 2024 · US
Co-crystals of a bruton's tyrosine kinase inhibitor
US-2022242868-A1 · Aug 4, 2022 · US
Crystalline forms of a brutons tyrosine kinase inhibitor
US-2022112196-A1 · Apr 14, 2022 · US
Solvated forms of a bruton's tyrosine kinase inhibitor
US-2022106317-A1 · Apr 7, 2022 · US
Synthesis of a bruton's tyrosine kinase inhibitor
US-2022098200-A1 · Mar 31, 2022 · US
Crystalline forms of a Bruton's tyrosine kinase inhibitor
US-10961251-B1 · Mar 30, 2021 · US
Crystalline forms of a brutons tyrosine kinase inhibitor
US-2021070759-A1 · Mar 11, 2021 · US
Recent patents
Latest publications not already listed above.
Crystalline forms of a brutons tyrosine kinase inhibitor
US-2021032258-A1 · Feb 4, 2021 · US
Synthesis of a bruton's tyrosine kinase inhibitor
US-2020347064-A1 · Nov 5, 2020 · US
Solvated forms of a bruton?s tyrosine kinase inhibitor
US-2020347063-A1 · Nov 5, 2020 · US
Crystalline forms of a brutons tyrosine kinase inhibitor
US-10752634-B2 · Aug 25, 2020 · US
Crystalline forms of a brutons tyrosine kinase inhibitor
US-2020231595-A1 · Jul 23, 2020 · US
Crystalline forms of a brutons tyrosine kinase inhibitor
US-2020223856-A1 · Jul 16, 2020 · US
Crystalline forms of a brutons tyrosine kinase inhibitor
US-2020148691-A1 · May 14, 2020 · US
Co-crystals of a bruton's tyrosine kinase inhibitor
US-2020031829-A1 · Jan 30, 2020 · US
Solvated forms of a bruton's tyrosine kinase inhibitor
US-2019367519-A1 · Dec 5, 2019 · US
Synthesis of a bruton's tyrosine kinase inhibitor
US-2019367518-A1 · Dec 5, 2019 · US
Crystalline forms of a bruton's tyrosine kinase inhibitor
US-2019248799-A1 · Aug 15, 2019 · US
Crystalline forms of a bruton's tyrosine kinase inhibitor
US-2019248798-A1 · Aug 15, 2019 · US
Crystalline forms of a Bruton's tyrosine kinase inhibitor
US-10294231-B2 · May 21, 2019 · US
Crystalline forms of a Bruton's tyrosine kinase inhibitor
US-10294232-B2 · May 21, 2019 · US
Crystalline forms of a Bruton's tyrosine kinase inhibitor
US-10266540-B2 · Apr 23, 2019 · US
Crystalline forms of a bruton's tyrosine kinase inhibitor
US-2018362536-A1 · Dec 20, 2018 · US
Crystalline forms of a bruton's tyrosine kinase inhibitor
US-2018362534-A1 · Dec 20, 2018 · US
Crystalline forms of a bruton's tyrosine kinase inhibitor
US-2018362535-A1 · Dec 20, 2018 · US
Crystalline forms of a bruton's tyrosine kinase inhibitor
US-2018327415-A1 · Nov 15, 2018 · US
Crystalline forms of a bruton's tyrosine kinase inhibitor
US-10125140-B1 · Nov 13, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Pharmacyclics Llc | 49 |
| Janssen Pharmaceutica Nv | 6 |
| Pharmacyclic s LLC | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/519 | 49 |
| C07D487/04 | 49 |
| A61P35/00 | 43 |
| A61P35/02 | 43 |
| A61P29/00 | 39 |